CAR-T Therapy

Bristol Myers Squibb, Cellares, CAR-T Therapy, Blood cancer, Abecma, Breyanzi, cell and gene therapy

Bristol Myers Squibb’s Bold Robotic Alliance with Cellares for Advanced CAR-T Production

Anika Sharma

In the realm of cutting-edge cell therapy, where innovation is the heartbeat and the promise of transformative treatments is the ...

CARsgen Therapeutics, Claudin18.2, Moderna, mRNA cancer vaccine, CT041, CAR-T therapy

CARsgen and Moderna Join Forces to Explore Synergy Between CT041 and mRNA Cancer Vaccine

Anika Sharma

CARsgen Therapeutics has set the stage for an intriguing partnership with Moderna that’s bound to heat up the cancer therapy ...

Carvykti, CAR-T Therapy, Johnson & Johnson, Bispecific antibody, Multiple myeloma

Carvykti CAR-T Therapy by J&J and Legend Biotech Persists Amid New Bispecific

Anika Sharma

Johnson & Johnson and Legend Biotech’s Carvykti maintains growth in the multiple myeloma market despite the emergence of a more ...

Johnson & Johnson (J&J) has taken a significant step towards gaining FDA approval for its CAR-T therapy, Carvykti, in the treatment of multiple myeloma

Johnson & Johnson (J&J) Moves Closer to FDA Approval for CAR-T Therapy

SG Tylor

The company has filed for approval to use Carvykti earlier in the treatment pathway, including for patients experiencing their first ...